Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-30 12:12 pm Purchase | 13D | Urovant Sciences Ltd. UROV | Sumitomo Chemical Co. Ltd. | 22,963,479 100.000% | 216 (+0.00%) | View |
| 2021-02-16 3:38 pm Purchase | 13G | Urovant Sciences Ltd. UROV | PERCEPTIVE ADVISORS LLC | 3,116,831 9.800% | 709,900 (+29.49%) | View |
| 2020-11-12 5:11 pm Purchase | 13D | Urovant Sciences Ltd. UROV | Sumitomo Chemical Co. Ltd. | 22,963,263 72.400% | 103,250 (+0.45%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | Urovant Sciences Ltd. UROV | PERCEPTIVE ADVISORS LLC | 2,406,931 7.900% | 808,654 (+50.60%) | View |
| 2020-01-06 08:40 am Purchase | 13D | Urovant Sciences Ltd. UROV | Sumitomo Chemical Co. Ltd. | 22,860,013 75.200% | 22,860,013 (New Position) | View |
| 2019-12-31 4:45 pm Sale | 13D | Urovant Sciences Ltd. UROV | Roivant Sciences Ltd. ROIV | 0 0.000% | -22,860,013 (Position Closed) | View |